↓ Skip to main content

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

Overview of attention for article published in Frontiers in oncology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
3 X users
patent
1 patent
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
205 Dimensions

Readers on

mendeley
236 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Published in
Frontiers in oncology, March 2022
DOI 10.3389/fonc.2022.819128
Pubmed ID
Authors

Yan Peng, Yuanyuan Wang, Cheng Zhou, Wuxuan Mei, Changchun Zeng

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 236 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 11%
Researcher 17 7%
Student > Bachelor 17 7%
Student > Master 12 5%
Student > Doctoral Student 9 4%
Other 29 12%
Unknown 126 53%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 35 15%
Medicine and Dentistry 15 6%
Pharmacology, Toxicology and Pharmaceutical Science 14 6%
Unspecified 11 5%
Chemistry 8 3%
Other 20 8%
Unknown 133 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2024.
All research outputs
#4,840,893
of 25,392,582 outputs
Outputs from Frontiers in oncology
#1,690
of 22,436 outputs
Outputs of similar age
#106,199
of 446,344 outputs
Outputs of similar age from Frontiers in oncology
#122
of 1,525 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 1,525 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.